Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial for Adolescents and Young Adults With Untreated Acute Lymphoblastic Leukemia (ALL)
NCT00558519Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2008
- Primary completion
- Sep 2016
- Modality
- DNA Intercalators/Alkylators, Therapeutic Enzymes, Orthosteric Ligands
01
Overview
A Phase 2 trial of cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin in acute lymphoblastic leukemia (ALL), sponsored by Cancer and Leukemia Group B. Started Mar 2008; status: completed.
02
Drugs
cyclophosphamidecytarabinedaunorubicindexamethasonedoxorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00558519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558519.